BOLETIN INFORMATIVO Nº 2 – Abril 2022
Estimados colegas del Programa Nacional de Control de Calidad en Bacteriología (PCC-NAC):
En el presente BOLETIN INFORMATIVO Nº2 enviamos:
- WHO REPORT: Extensively drug-resistant Shigella sonnei infections – Europe.World Health Organization.
- Increase in extensively-drug resistant Shigella sonnei infections in MSM, in the EU/EEA and UK- European Centre for Disease Prevention and Control. 23 February 2022. ECDC: Stockholm; 2022.
- CRE, CREO, CPE and CPO terminology past its sell by date in an area of new antibiotics and regional carbapenemase epidemiology. D. Livermore Clin Infect Dis. 2020 Oct 23; 71 (7):1776-1782. doi: 10.1093/cid/ciaa122.
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli. Clin Microbiol Infect. 2021 Dec 16:S1198-743X (21)00679-0. doi: 10.1016/j.cmi.2021.11.025.
Cariños para todos!
Alejandra y Paola
Servicio Antimicrobianos
LNR/LRR en Resistencia a los Antimicrobianos
INEI-ANLIS. “Dr. Carlos G Malbrán”
